Monarch LifeSciences351 West Tenth Street, Suite 350 |
|
To provide the best commercially available proteomics services for biomarker discovery, validation and application and to meticulously validate emerging technologies for specific applications.
Shawn Comella, CEO
317.278.6154
scomella@monarchlifesciences.com
Monarch LifeSciences began in 2003 as The Indiana Centers for Applied Protein Sciences (INCAPS). It was one of eight initiatives conceived by BioCrossroads, an innovative collaboration among industry, academia and government in the life sciences. Launched in 2004, Monarch began working on proteomics projects for regional pharma and academic customers. The company has since quadrupled the number of its employees and expanded their expertise to focus on biomarker discovery, validation and application. Of particular interest is their high throughput mass spec-based protein assay (LifeMarker™ Assays). Biotech and Pharmaceutical companies across the US and Europe are increasingly relying on Monarch’s services to support their research goals